If you’re considering applying for our Limited Competition: NIGMS National and Regional Resources (R24 – Clinical Trial Not Allowed) announcement (PAR-19-301) for the September 26 receipt date, don’t miss our upcoming webinar:

Monday, August 5, 1:00-2:00 p.m. ET

We’re offering administrative supplements to NIGMS-funded P20, P30, P41, R01, R35, R37, and RM1 awards for the purchase of helium recovery systems. The deadline for these supplement applications is August 5, 2019.

Note that:

UPDATE: The slides [PDF, 296KB] from the National and Regional Resources Webinar have been posted.

Research resources provide access to technologies, methods, and expertise that are not generally available to individual laboratories. Large-scale research resources can significantly broaden access to cutting-edge technologies and can achieve economies of scale not possible for facilities serving individual institutions.

We have just published a new funding
opportunity announcement (FOA) to support national and regional (multistate) resources for biomedical research that will provide access to state-of-the-art facilities, equipment, technologies, research tools, and software to many users. We expect the impact of these resources and the number of users to be on a similar scale to what is achieved by synchrotron beamlines and cryo-electron microscopy centers.

As announced earlier in the fiscal year, NIGMS is offering administrative supplements to NIGMS-funded R01, R35, and R37 awards for the purchase of single pieces of equipment.

The deadline for these supplement applications has been extended to June 25, 2019.

I’m pleased to announce the debut of Pathways, a collaboration between NIGMS and Scholastic, Inc., that provides a collection of free educational resources about basic biomedical science and research careers.

To continue our efforts to catalyze the modernization of biomedical graduate education, we invite eligible NIGMS-funded T32 predoctoral training programs to submit administrative supplement requests (NOT-GM-19-015) to develop new curricular and training activities that enhance the program’s ability to: 1) provide graduate trainees with a strong foundation in research design and methods in areas related to conducting rigorous and transparent research to enhance reproducibility; 2) prepare students for diverse careers in the biomedical research workforce; 3) develop the knowledge and skills of trainees to enhance laboratory safety; and 4) develop the technical, operational, and professional skills of predoctoral biomedical researchers.

UPDATE: Consult the MIRA webpage or your program officer for the current notices of funding opportunities.

Since supplemental grant funding comes in a variety of flavors, with different purposes, it’s not surprising that there’s confusion about which kinds of supplements MIRA grantees may apply for and which they may not. Here’s a quick run-down.

We're pleased to announce the launch of our redesigned website, https://www.nigms.nih.gov. Among the site’s new and improved features:

• Easier navigation with fewer clicks
• Modern, visually appealing look
• Enhanced science education pages
• Improved search functionality
• Format that's both computer- and mobile-friendly
• And more!

NIGMS, along with other NIH Institutes and Centers, has partnered with the National Institute on Aging to grow the community of scientists actively engaged in research focused on Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD). Details of this year’s AD/ADRD supplement program are provided in NIA’s Notice NOT-AG-18-008. If your research, research training, or research capacity-building grant is not currently focused on AD/ADRD and you have an inspiring new idea of potential value to the field that is within the scope of the funded Specific Aims of your current award, please consider this opportunity.

Research related to AD/ADRD might fall within the scope of an already-funded NIGMS award originally focused on, for example, an enzyme, transporter, or metabolic pathway being studied for its basic biological or physiological role (or a non-AD/ADRD-related medical condition) if you have recognized an exciting new implication for AD-type pathologies or their treatment. Funded projects developing analytical methods, tools or technologies, drug molecules, or drug delivery systems not previously intended for application to AD/ADRD might now appear to have potential in this area. Potential applicants are strongly encouraged to contact their program director to discuss their ideas for AD/ADRD research and how those relate to the Specific Aims currently funded. Decisions about scope are strictly the purview of NIH. Center and Resource grants that allow non-specified pilot projects should consider adding AD/ADRD projects if interest and expertise exist.

To continue our efforts to catalyze the modernization of biomedical graduate education, we invite eligible NIGMS-funded T32 predoctoral training programs to submit administrative supplement requests to develop new curricular and training activities to enhance the program’s ability to: 1) provide graduate trainees with a strong foundation in research design and methods in areas related to conducting rigorous and transparent research to enhance reproducibility (PA-18-756); 2) prepare students for diverse careers in the biomedical research workforce (PA-18-757); 3) develop the knowledge and skills of trainees to enhance laboratory safety (PA-18-758); and 4) develop the technical, operational, and professional skills of predoctoral biomedical researchers (PA-18-759). Grantees should consider the following before applying: